NeoINK Bio is an innovative start-up backed by the Sofinnova Telethon fund which conducts research activities in collaboration with the Diabetes Research Institute (DRI) at Ospedale San Raffaele in Milan.

NeoINK Bio develops non-invasive approaches to support cellular therapies for metabolic and endocrine diseases with high unmet medical need.